Neighbourhood walkability and dietary attributes: effect modification by area-level socio-economic status.


Journal

Public health nutrition
ISSN: 1475-2727
Titre abrégé: Public Health Nutr
Pays: England
ID NLM: 9808463

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 19 5 2022
medline: 12 8 2022
entrez: 18 5 2022
Statut: ppublish

Résumé

Higher neighbourhood walkability would be expected to contribute to better health, but the relevant evidence is inconsistent. This may be because residents' dietary attributes, which vary with socio-economic status (SES) and influence their health, can be related to walkability. We examined associations of walkability with dietary attributes and potential effect modification by area-level SES. The exposure variable of this cross-sectional study was neighbourhood walkability, calculated using residential density, intersection density and destination density within 1-km street-network buffer around each participant's residence. The outcome variables were dietary patterns (Western, prudent and mixed) and total dietary energy intake, derived from a FFQ. Main and interaction effects with area-level SES were estimated using two-level linear regression models. Participants were from all states and territories in Australia. The analytical sample included 3590 participants (54 % women, age range 34 to 86). Walkability was not associated with dietary attributes in the whole sample. However, we found interaction effects of walkability and area-level SES on Western diet scores ( Higher walkability may not be necessarily conducive to better health in socio-economically disadvantaged areas. Public health initiatives to enhance neighbourhood walkability need to consider food environments and socio-economic contexts.

Identifiants

pubmed: 35583044
pii: S1368980022001197
doi: 10.1017/S1368980022001197
pmc: PMC9991640
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2593-2600

Références

Health Promot J Austr. 2017 Mar;28(1):82-84
pubmed: 27376397
Circulation. 2012 Jul 3;126(1):126-32
pubmed: 22753534
Lancet. 2016 Dec 10;388(10062):2912-2924
pubmed: 27671668
Obes Rev. 2019 Jan;20(1):41-54
pubmed: 30253075
Diabetes Care. 2016 Nov;39(11):2065-2079
pubmed: 27926890
Public Health Nutr. 2020 Dec;23(17):3197-3203
pubmed: 32844738
Curr Opin Lipidol. 2002 Feb;13(1):3-9
pubmed: 11790957
Int J Behav Nutr Phys Act. 2015 May 22;12:68
pubmed: 25997451
Nutr Res Rev. 2018 Jun;31(1):16-34
pubmed: 29037273
Aust N Z J Public Health. 2000 Dec;24(6):576-83
pubmed: 11215004
Int J Environ Res Public Health. 2019 Feb 20;16(4):
pubmed: 30791631
Lancet. 2017 Dec 16;390(10113):2643-2654
pubmed: 28943267
Int J Environ Res Public Health. 2019 Aug 28;16(17):
pubmed: 31466371
BMC Public Health. 2014 Mar 06;14:233
pubmed: 24602291
Annu Rev Public Health. 2020 Apr 2;41:417-432
pubmed: 31900101
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
J Am Heart Assoc. 2019 Nov 5;8(21):e013146
pubmed: 31665997
Am J Prev Med. 2012 May;42(5):e47-55
pubmed: 22516503
Health Place. 2012 Sep;18(5):1172-87
pubmed: 22717379
Int J Behav Nutr Phys Act. 2017 Nov 16;14(1):158
pubmed: 29145884
Int J Behav Nutr Phys Act. 2019 Oct 15;16(1):86
pubmed: 31615522
Health Place. 2016 May;39:9-17
pubmed: 26922513
J Diabetes. 2021 Aug;13(8):661-671
pubmed: 33403802
Health Place. 2019 Jan;55:43-50
pubmed: 30470615
Annu Rev Public Health. 2020 Apr 2;41:119-139
pubmed: 32237990
Obes Rev. 2020 Feb;21(2):e12941
pubmed: 31802612
Diabetes Res Clin Pract. 2002 Aug;57(2):119-29
pubmed: 12062857

Auteurs

Manoj Chandrabose (M)

Centre for Urban Transitions, Swinburne University of Technology, Hawthorn, VIC3122, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.

Yingting Tina Cao (YT)

Baker Heart and Diabetes Institute, Melbourne, Australia.
Nossal Institute for Global Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Nyssa Hadgraft (N)

Centre for Urban Transitions, Swinburne University of Technology, Hawthorn, VIC3122, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.

Carl Higgs (C)

Centre for Urban Research, RMIT University, Melbourne, Australia.

Faysal Shuvo (F)

Centre for Urban Transitions, Swinburne University of Technology, Hawthorn, VIC3122, Australia.

David W Dunstan (DW)

Baker Heart and Diabetes Institute, Melbourne, Australia.
Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

Neville Owen (N)

Centre for Urban Transitions, Swinburne University of Technology, Hawthorn, VIC3122, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.

Takemi Sugiyama (T)

Centre for Urban Transitions, Swinburne University of Technology, Hawthorn, VIC3122, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH